Erdafitinib in BCG-treated high-risk non-muscle-invasive bladder cancer. - Catto, J.W.F.; Tran, B.; Rouprêt, M.; Gschwend, J.E.; Loriot, Y.; Nishiyama, H.; Redorta, J.P.; Daneshmand, S.; Hussain, S.A.; Cutuli, H.J.; Procopio, G.; Guadalupi, V.; et al. (Annals of Oncology, 2024)